Introduction
============

*Klebsiella pneumoniae* is one of the most frequent causes of both health care- and community-associated infections, including pyogenic liver abscess, urinary tract infections, bacteremia, and pneumonia ([@B17]). One changing trend is the increase of antimicrobial resistance in hypervirulent *K. pneumoniae*, especially the emergence of carbapenemase producing hypervirulent *K. pneumoniae* (CP-hvKP), which has increasingly caused serious global public health concern ([@B40]).

New Delhi metallo-β-lactamase (NDM) carbapenemase is increasingly being reported in different parts of the world ([@B25]). A few of them have been tested for their enzymatic kinetics, which denotes that amino acid substitution is a major source of metallo-β-lactamase (MBL) activity extension ([@B13]). NDM-5 differs from existing enzymes due to substitutions at positions 88 (Val→Leu) and 154 (Met→Leu), which appear to confer increased resistance to carbapenems and broad-spectrum cephalosporins. After the first identification in China ([@B38]), the incidence of NDM-5 expression by *Escherichia coli* has increased dramatically. However, NDM-5 carbapenemases remain very rare in *K. pneumoniae*. Moreover, little is known about the virulence potential of NDM-5-producing *K. pneumoniae*.

Although genomes of many human-source hvKP (e.g., NTUH K2044, KPNIH31, Kp13, 65BO, and KCTC 2242) have been sequenced, only three genomes of K2-hvKP (KP617, PittNDM01, and CG43) have been obtained ([@B37]; [@B28]; [@B32]). The genome sequences of K2-hvKP isolates with multidrug resistance and high virulence have not been published previously. In order to investigate the mechanisms involved in the multidrug resistance and increased virulence in K2-hvKP in China, the genomic profile of a K2-hvKP isolate with relative higher virulence and carbapenem resistance was determined by the *de novo* sequencing technology in the present study.

Materials and Methods {#s1}
=====================

Patient and Isolates
--------------------

In April 4, 2015, a 65-year-old female was hospitalized in the First Affiliated Hospital of Nanchang University, China, for a cerebral infarction. In addition, the patient has the following diseases: coronary atherosclerotic heart disease, hypertension, type 2 diabetes, and hyperlipoidemia. At that time, the white blood cell (WBC) count was 8.2 × 10^9^/L with 65.1% granulocytes and 19.8% lymphocytes. However, on April 12, her WBC count increased to 15.5 × 10^9^/L with unusual 87.5% granulocytes and 6.3% lymphocytes, accompanied by a high temperature, breathing difficulty, and brick red foamy blood sputum, and followed by respiratory distress syndrome. Furthermore, the patient developed pneumonia and bacteriuria that was empirically treated with ceftazidime, ciprofloxacin, and metronidazole. The clinical status of the patient worsened necessitating intubation and mechanical ventilation on day 8, and her transfer on day 11 to the intensive care unit and died at 4 am, on April 16.

*Klebsiella pneumoniae* strain 24835 was isolated from midstream urine specimen. The isolate was identified using the VITEK 2 (BioMérieux, France). Further identification of *K. pneumoniae* was performed by partially sequencing the 16S rRNA gene ([@B19]). In addition, the hypermucoviscous (HV) phenotype was tested by evaluating the formation of a viscous string (positive test, \>0.5 cm in length) that was stretched using an inoculation loop ([@B31]).

Antimicrobial Susceptibility Testing and Detection of Resistance Mechanisms
---------------------------------------------------------------------------

Antimicrobial susceptibilities for the *bla*~NDM--5~ positive isolates and transconjugants were initially tested using the VITEK 2 system (BioMérieux, France) and then were followed by measuring minimum inhibitory concentration (MIC) using the microbroth dilution method (for ampicillin/sulbactam, piperacillin/tazobactam, cefazolin, cefotetan, ceftazidime, cefepime, imipenem, ertapenem, ciprofloxacin, levofloxacin, gentamicin, amikacin, and aztreonam) and E-test (AB bioMérieux, Sweden) (for tigecycline), respectively. The standard microbroth methods were performed according to the guideline M07-A9 of the [@B11]. E-tests were conducted according to packet insert instructions using Mueller--Hinton agar (MHA). Fresh bacterial colonies taken directly from MHA plates that were incubated at 37°C for 16--20 h were re-suspended in sterile Mueller--Hinton broth to obtain a suspension of 0.5 McFarland turbidity. *E. coli* ATCC 25922 was used as the quality control. The MIC results were interpreted according to the CLSI guidelines M100-S25 ([@B11]). The Food and Drug Administration (FDA) breakpoint was used for tigecycline.

Double disc synergy tests (DDSTs) using imipenem/ethylenediaminetetraacetic acid (EDTA) and aztreonam and amoxicillin/clavulanic acid were employed to screen for metallo-β-lactamases and extended spectrum beta-lactamases (ESBLs), respectively. Isolate was screened by polymerase chain reaction (PCR) amplification using a panel of primers for the detection of MBLs, *Klebsiella pneumoniae* carbapenemases (KPCs), OXA-48, ESBLs, including the SHV, TEM, CTX-M, and IBC/GES enzymes, and plasmid-mediated AmpCs ([@B12]; [@B27]; [@B2]).

*De novo* Whole-Genome Sequencing of *K. pneumoniae* 24835
----------------------------------------------------------

Total genomic DNA of *K. pneumoniae* 24835 was extracted using QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's protocol. The genomic DNA was sent to Shanghai Biotechnology Corporation for the *de novo* whole-genome sequencing. A combination of Illumina MiSeq (300 bp paired-end, 12 million reads) and PacBio (10 kb fragment library, 356,001 reads) sequencing data were used to assemble the genome using SPAdes version 3.1.0 ([@B26]). The Prokka program was employed for annotating the genomic sequence. Gene prediction was carried out using Glimmer 3.02, tRNA prediction with tRNAscan-SE, and rRNA prediction with HMMER, while basic local alignment search tool (BLAST) searches were performed against several databases including CatFam, COG, NCBI RefSeq, and SEED.

The acquired antimicrobial resistance genes were identified by uploading assembled genomes to the Resfinder server v2.1^[1](#fn01){ref-type="fn"}^. The other genes relating to resistance and virulence were detected using the mapping unit of CLC Genomics Workbench to map reads and/or by blasting assembled genomes to a pseudomolecule generated by concatenating a set of *K. pneumoniae* genes. Scaffolds with resistance-related and virulence genes were blasted against GenBank to identify their genetic location. The sequence data from *K. pneumoniae* 24835 was compared to the results of antimicrobial resistance and virulence to identify genetic factors that correspond to the observed mechanisms.

Plasmid Analysis and Horizontal Gene Transfer of pNDM-5
-------------------------------------------------------

Horizontal gene transfer of pNDM-5 was evaluated by transconjugation assays using 10^6^ colony forming units (cfu) of 24835 as a donor and 10^6^ cfu of *E. coli* J53 as recipients. After 24 h incubation, transconjugants were selected on MHA containing sodium azide (100 μg/ml) and imipenem (1 μg/ml). The presence of *bla*~NDM--5~ in transconjugants was confirmed using PCR and enterobacterial repetitive intergenic consensus polymerase chain reaction (ERIC-PCR) was used for further distinguishing transconjugants from the donor strain. Plasmid DNA that was prepared from the transconjugant using alkaline lysis was subjected to PCR-based replicon typing ([@B9]; [@B16]). The resultant plasmids were annotated using the Prokaryotic 6 Genomes Automatic Annotation Pipeline (PGAAP) available at NCBI^[2](#fn02){ref-type="fn"}^. The plasmid was compared to publicly available plasmid references using BLAST at GenBank^[3](#fn03){ref-type="fn"}^. The plasmid comparison and visualization were generated by Easyfig (version 2.2.2) ([@B33]).

Pulsed Field Gel Electrophoresis (S1-PFGE)
------------------------------------------

Pulsed field gel electrophoresis (S1-PFGE) was performed to determine the number and size of plasmids carried by strain 24835 as described previously. Briefly, agarose plugs containing whole-cell DNA of strain 24835 were treated with 8 U of S1 nuclease (Fermentas, Thermo Scientific, Waltham, MA, USA) and the reaction was stopped by adding 0.5 M EDTA (pH = 8). PFGE was conducted with a 1% SeaKem Gold agarose gel (Lonza, Basal, Switzerland) using a CHEF DRII system (Bio-Rad, Hercules, CA, USA) at 14°C, with a 6-V/cm current and run times of 12 h at switch time of 5--40 s followed by 8 h at switch time of 3--8 s. MidRange I PFG Marker (NEB, Ipswich, MA, USA) was used for size estimation.

Multilocus Sequence Typing
--------------------------

Multilocus sequence typing (MLST) on the *K. pneumoniae* were performed as previously described ([@B22]).

Serum Killing Assay
-------------------

Human blood was obtained from 10 healthy individuals. Pooled serum was separated and stored in small volumes at −80°C until use. Serum killing assay was performed as previously described. An inoculums of 25 μL (adjusted to 10^6^ cfu/ml) prepared from the mid-log phase was diluted by 0.9% saline, and was added to 75 μL of pooled human sera contained in a 10 × 75 mm Falcon polypropylene tube (BD Biosciences, Franklin Lakes, NJ, USA). Serial dilutions were plated on MHA for 0, 1, 2, and 3 h to obtain colony counts.

1.  Grade 1 is viable counts \<10% of the inoculum after 1 and 2 h, and \<0.1% after 3 h.

2.  Grade 2 is viable counts 10--100% of the inoculum after 1 h and \<10% after 3 h.

3.  Grade 3 is viable counts that exceeded those of the inoculum after 1 h, but \<100% after 2 and 3 h.

4.  Grade 4 is viable counts \>100% of the inoculum after both 1 and 2 h, but \<100% after 3 h.

5.  Grade 5 is viable counts \>100% of the inoculums 1, 2, and 3 h, but that decreased during the third hour.

6.  Grade 6 is viable counts that exceeded those of the inoculum after 1, 2, and 3 h, and increased throughout this time period.

Each strain was tested at least three times, and the mean results were expressed as percent inoculums. The results were expressed as percentage of inoculation and the responses in terms of viable counts were graded from 1 to 6, as previously described ([@B1]). A strain was defined as serum sensitive at grades of 1--2, intermediately sensitive at grades of 3--4, and resistant at grades of 5--6. *K. pneumoniae* ATCC 700603 and 19432 (NDM-1 positive) strains are used for comparison in the serum killing assay.

Mouse Lethality Assay
---------------------

To determine the 50% lethal dose (LD50), pathogen-free, 6- to 8-week-old, male BALB/c mice were obtained from Nanchang University Animal Center. Six mice were used as a sample population for each bacterial concentration. Ten-fold serial dilution of cfu of *K. pneumoniae* was made from a starting concentration of 10^6^ cfu/ml -10 cfu/ml, and BALB/c mice were infected intraperitoneally with 0.1 ml of each concentration ([@B40]). Symptoms and mortality rates were observed for 14 days. The exact inoculation dose was confirmed on Luria-Bertani (LB) agar and the LD50 was calculated as described by [@B41]. Survival curves were assessed by Kaplan--Meier analysis and log-rank test. *P* \< 0.05 was considered statistically significant. *K. pneumoniae* ATCC 700603 and 19432 (NDM-1 positive) strains are used for comparison in the mouse lethality assay.

Nucleotide Sequence Accession Numbers
-------------------------------------

The whole-genome shotgun project of *K. pneumoniae* 24835 has been deposited at GenBank under the accession number [CP014004](CP014004). The annotated sequences of p24835-NDM5 and p24835-CTXM15 have been submitted to GenBank nucleotide sequence database under accession numbers [CP014005](CP014005) and [CP014006](CP014006), respectively.

Results
=======

Isolation of a NDM-5 Positive *K. pneumoniae* Isolate
-----------------------------------------------------

A carbapenem-resistant *K. pneumoniae* isolate (termed 24835) at \>10^6^ cfu/ml was recovered from urine on April 13, 2015. The patient was isolated in a single room and treated according to national and local infection control guidelines. This included an extensive terminal disinfection of the sickroom after discharge of the patient. The patient had no recent history of travel outside. 24835 were resistant to all antibiotics recommended by CLSI for the susceptibility testing of *Enterobacteriaceae*, with both isolates exhibiting identical MIC values (**Figure [1](#F1){ref-type="fig"}** and Supplementary Table [S2](#SM2){ref-type="supplementary-material"}). Phenotypic ESBL and AmpC screening by DDST was positive, and PCR analyses and subsequent sequencing revealed the presence of *bla*~TEM--1B~, *bla*~SHV--28~, and *bla*~CTX--M--15~. The DDST with imipenem/EDTA was positive, suggesting the production of a metallo-β-lactamase, which was verified by PCR detection of *bla*~NDM--5~.

![**Schematic circular genome of *K. pneumoniae* 24835 strain.** From outside to inside, there were four rings. The first circle shows COG functional annotations. The second circle are rRNA and tRNA (red-tRNA, blue-rRNA). The third circle is the GC contents. The fourth circle is the GC skew with + value (orange) and -value (purple).](fmicb-08-00335-g001){#F1}

Genome Sequencing and Analysis
------------------------------

A total of 4,001,934 (1,208,584,068 bp) paired-end reads were generated using Illumina-HiSeq 2500. Using the PacBio RS II platform, 64,416 (941,657,914 bp) raw reads were produced. The complete genome of 24835 consists of a 5,387,996-bp circular chromosome and two plasmids of 101,030 and 46,161 bp in size. The genomic features of 24835 and the reference strains are summarized in **Figure [1](#F1){ref-type="fig"}**. Based on a Prokka analysis, 5191 putative open reading frames (ORFs) and 84 RNA genes on the circular chromosome (**Figure [1](#F1){ref-type="fig"}**; Supplementary Table [S1](#SM1){ref-type="supplementary-material"}), 108 putative ORFs on plasmid 1, and 49 putative ORFs on plasmid 2 were identified.

Nineteen antibiotic resistance genes were identified in the genome of 24385 strain. The β-lactam resistance genes in the 24385 genome were *bla*~TEM--1B~ and *bla*~SHV--28~ in the chromosome, *bla*~CTX--M--15~ in plasmid 1, and *bla*~NDM--5~ in plasmid 2 (Supplementary Figure [S1](#SM3){ref-type="supplementary-material"}). The clinical features of *K. pneumoniae* infections depend on the virulence factors expressed by the infecting strain ([@B39]). A BLAST search was performed against virulence factors database (VFDB) to identify 120 virulence factors harbored by the 24385 strain. The 120 virulence genes of 24385 strain were classified into 31 the following categories: Iron uptake (32 genes), Immune evasion (12 genes), Endotoxin (11 genes), Adherence (11 genes), Fimbrial adherence determinants (8 genes), Toxin (7 genes), Antiphagocytosis (6 genes), Regulation (5 genes), Acid resistance (3 genes), Anaerobic respiration (2 genes), Cell surface components (2 genes), and Secretion system (2 genes). Among the 120 virulence genes identified, 8 genes were lipopolysaccharide (LPS)-related genes and 4 genes were capsular polysaccharide-related.

Identification, Transferability, and Genetic Context of *bla*~NDM--5~ in 24835
------------------------------------------------------------------------------

*bla*~NDM--5~ was successfully transferred to *E. coli* J53, suggesting its localization on a plasmid. Strikingly, the conjugation frequency was high. Plasmid p24835-NDM5 was readily transferred from *K. pneumoniae* 24835 to *E. coli* J53Az^R^ with a frequency of (2.4 ± 0.9) × 10^-4^ per donor cell at 37°C.

Transconjugants expressing NDM-5 were non-susceptible to all tested β-lactam antibiotics, including aztreonam, suggesting the presence of other β-lactamases besides NDM-5 on the plasmid (Supplementary Table [S2](#SM2){ref-type="supplementary-material"}). Transconjugants were positive for *bla*~CTX--M--15~, but negative for *bla*~SHV--28~, confirming the results of phenotypic testing. NDM-carrying transconjugants were furthermore sensitive to gentamicin and amikacin, indicating the absence of aminoglycoside resistance genes. Plasmid p24835-NDM5 carrying the *bla*~NDM--5~ gene was 46,161 bp in length, with an average GC content of 52.04% (**Figure [2A](#F2){ref-type="fig"}**). It possessed 114 ORFs, including those corresponding to the replication, conjugation, and antibiotic resistance modules. Its scaffold corresponded to that of IncX3-type plasmids, commonly identified among enterobacterial isolates. In particular, it showed similarities with plasmid pNDM-MGR194, which was recently identified at the origin of the *bla*~NDM--1~ gene acquisition in a *K. pneumoniae* isolate in India ([@B18]). Comparative analysis of the genetic contexts of *bla*~NDM--5~ in this IncX3 plasmid and the previously reported plasmids revealed some differences (**Figure [2B](#F2){ref-type="fig"}**).

![**Plasmid analysis of p24835-NDM5. (A)** Schematic map of plasmid p24835-NDM5, ORFs are color coded according to predicted function as indicated in the associated key. Arrows show the direction of transcription; **(B)** comparative analysis of plasmid structures between p524835-NDM (CP014006) and the reference plasmids pNDM-MGR194 (KF220657), pNDM-QD29 (KU167609), pKN5047 (KC311431), pNDM-HN380 (JX104760), and pEc1929 (KT824791). The identical regions are highlighted in red.](fmicb-08-00335-g002){#F2}

Detection of Virulence-Associated Determinants, Serum Killing, and Mouse Lethality Assay
----------------------------------------------------------------------------------------

MLST showed that 24835 isolate was ST14. The strain was confirmed as serotype K2 and aerobactin-kfu-rmpA positive (Supplementary Figure [S2](#SM4){ref-type="supplementary-material"}). The identified virulence determinants may have contributed to the infection and or colonization of *K. pneumoniae* 24835 in the urinary tract. Furthermore, the isolate grew as positive HV phenotype with a mucoviscous string \>5 mm in length from the colony on the blood agar plate (Supplementary Figure [S2](#SM4){ref-type="supplementary-material"}), however, the fact was observed after initial isolation of the bacterium, and, thereafter, the characteristic decreased.

Serum killing resistance (grade 6) was found in strain 24835. The other two isolates (ATCC 700603 and 19432) showed serum sensitive (grade 1 or 2) (**Figure [3](#F3){ref-type="fig"}**). Mouse lethality assay was used to study the virulence *in vivo*. The results showed that LD50 of \>10^6^ cfu, which indicates low virulence, was identified in a NDM-1-producing strain 19432 and ATCC 700603. In contrast, strain 24835 was shown hypervirulent, as all mice injected with this strain died within 7 days at a low concentration (**Figure [4](#F4){ref-type="fig"}**). LD50 of strain 24835 was 105.2 cfu (\<10^3^ cfu), exhibiting a high virulence level of "+++" according to previously described, which is in line with studies from [@B36] who also reported an LD50, 120 cfu for highly virulent KPC-producing strain. This shows that the NDM-5-containing clinical isolate 24835 was more virulent than ATCC 700603 and the other, NDM-1 positive, *K. pneumoniae* strain 19432.

![**Serum killing assay of 24835, 19432, and ATCC 700603 strains.** Survival of each strain was assessed by enumerating viable counts at 0, 1, 2, and 3 h of incubation in the pooled human sera at 37°C. There was a significant increase in the growth of the strain 24835. Data shown are mean ± SEM of triplicates.](fmicb-08-00335-g003){#F3}

![**Mouse lethality assay of 24835, 19432, and ATCC 700603 strains.** The mortality of mice after intraperitoneal injection of all strains was observed over 14 days. Data points represented the percentage of mice survival in each group (*n* = 6 mice per strain). A significant difference in mice lethality was identified between strain 24835 and the other strains (*P* \< 0.001).](fmicb-08-00335-g004){#F4}

Discussion
==========

So far, compared to serotype K1 HvKP, not much has been studies about K2 strains. Serotype K2 hvKP (K2-hvKP) also has significant clinical importance due to their ability to cause life threatening and metastatic infections ([@B40]). Clonal complexes of K2-hvKP and multidrug resistant strains had been considered independent until 2015, when carbapenem-resistant K2-hvKP were first identified in China ([@B40]). The carbapenem resistant K2-hvKP may greatly threaten human public health, therefore it is important to investigate the virulence potential and mechanism involved in carbapenem resistance and virulence of K2-hvKP.

24835 had multidrug resistance to fluoroquinolones, carbapenem, cephalosporins, monobactams, and fosfomycin. The *oqxA* and *oqxB* gene contributed to its high-level resistance to fluoroquinolones ([@B4]). High level cephalosporins and monobactams resistance in *K. pneumoniae* 24835 was likely due to *bla*~CTX--M--15~, *bla*~SHV--28~, and *bla*~TEM--1B~ ([@B24]; [@B7]; [@B35]). The *fosA3* gene contributed to its high-level resistance to fosfomycin ([@B15]). The high-level resistance to carbapenem was mediated by *bla*~NDM--5~ gene which was located in p24835-NDM5 plasmid ([@B34]). The p24835-NDM5 plasmid in 24835 was identical to the one found in pNDM-MGR194 ([@B30]). As a mobile gene element, p24835-NDM5 plasmid may act as a vehicle to pick up and spread multiple antibiotic resistance genes and virulence genes in *K. pneumoniae* ([@B6]). The *aadA2* gene in 24835 could explain its intermediate to tobramycin.

Generally, it has been through that multidrug resistance is often associated with higher fitness costs or less virulence ([@B14]). However, our study suggested that the multidrug resistant 24835 had higher virulence than the reference strain ATCC 700603 and 19432 that are not multidrug resistant. Previous studies indicated that an association of CTX-M enzyme production with virulence and fitness in *K. pneumoniae* ([@B29]). A recent study further revealed that the expression of both efflux systems and porins is a key factor not only for antibiotic resistance but also virulence potential in *K. pneumoniae* ([@B20]). However, another study suggests that known virulence factors such as K1, K2, and K5 capsular polysaccharides, rmpA and the aerobactin gene were absent in KPC-producing isolates and these strains present low virulence in a murine lethality model ([@B10]). Some of the clinical investigation data indicated the positive correlation between virulence and resistance, but others indicated the negative correlation ([@B21]; [@B23]). Our study revealed the relationship between multidrug resistance and virulence of *K. pneumoniae* 24835, indicating that complex mechanisms may work together to cause multidrug resistance and the relative higher virulence.

24835 contained some special virulence-associated genes and proteins, including *ureA*, *fimH*, *uge*, *wabG*, *mrkD*, Quorum sensing system, capsule polysaccharide protein, exoenzyme and iron uptake system. The *urea* is related to the urease operon, which is involved in urea metabolism and required for efficient bacterial gastrointestinal colonization. The *fimH*, encoding adhesin, may play an important role on the colonization, invasion, and biofilm formation of 24835 ([@B8]). The presence of *uge* may contribute to the expression of smooth LPS with O antigen molecules and capsule polysaccharide on the cell surface, yielding the ability to produce a UTI and virulence during sepsis and pneumonia of *K. pneumoniae* 24835. The *wabG* may play a critical role in the cell attachment of capsular polysaccharide and contribute to the biosynthesis of the core LPS and encapsulated cell ([@B3]). The *mrkD* encodes the type 3 fimbriae adhesin, which facilitates adhesion to the basement membranes of several human tissue ([@B5]). The quorum sensing system, capsule polysaccharide protein, exoenzyme and iron uptake system may enhance the invasion, colonization, and biofilm formation of 24835 in reservoir hosts and mediate the virulence of 24835 by evading host immune response. These results also show the emergence of dual-risk *K. pneumoniae* strain combining both virulence and multidrug resistance features. Therefore, acquisition of an important mechanism of carbapenem resistance, such as NDM-5 in the virulent strain, may be a concern in the future. Future experiments are needed to find the deeper molecular mechanisms and confirm the function of some important gene elements on multidrug resistance and relative higher virulence.
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